Share chart AusCann Group Holdings Ltd
Extended chart
Simple chart
About
AusCann Group Holdings Ltd engages in the development and commercialization of cannabinoid-derived therapeutic products for humans and animals in Australia and internationally. Its principal product includes the novel tetrahydrocannabinol and cannabidiol (THC/CBD), a powder-based hard-shell capsules based on AusCann's Neuvis platform for the treatment of pain and related indications. The company is also involved in the research and development of medicinal cannabis. It offers its products to healthcare professionals and veterinarians. More detailsIndustry | Pharmaceuticals |
---|---|
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Сайт | https://auscann.com.au |
Цена ао | 0.0038 |
Change price per day: | 0% (0.0038) |
---|---|
Change price per week: | -38.71% (0.0062) |
Change price per month: | -72.06% (0.0136) |
Change price per 3 month: | -69.6% (0.0125) |
Change price per half year: | +26.67% (0.003) |
Change price per year: | +22.58% (0.0031) |
Change price per 3 year: | -95.03% (0.0765) |
Change price per 5 year: | -98.54% (0.26) |
Change price per year to date: | +137.5% (0.0016) |
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
Head | Job title | Payment | Year of birth |
---|---|---|---|
Mr. Christopher Mews A.C.I.S., B. Bus, C.P.A. | Chief Financial Officer | ||
Ms. Rachel Jelleff Kerr | Company Secretary |
Address: Australia, West Perth, 1202 Hay Street - open in Google maps, open in Yandex maps
Website: https://auscann.com.au
Website: https://auscann.com.au